AAGH 10-K & 10-Q changes, risk factors and insider trading
America Great Health · OTC · Pharmaceutical Preparations · CIK 1098009 · All filings on SEC.gov
At a glance
What changed in the latest 10-K
Risk Factors
This item is inapplicable because we are a “smaller reporting company” as defined in Exchange Act Rule 12b-2.
No wording changes found in this section.
Full comparison: every changed paragraph (0)
Management's Discussion & Analysis (MD&A)
Largest changes
“On September 3, 2021, the Company entered into an Assets Acquisition Agreement with Wang’s Property Investment & Management LLC to purchase 53 units in 19 real estate properties appraised at $7,626, 286.37 for a purchase price of $7,000,000, The purchase price shall be paid as follows: (i) $1,000,000 on execution of the Agreement, (ii) $2,000,000 within 60 days thereof and (iii) the remainder by April 10, 2022. The Agreement is subject to customary closing conditions, including, satisfactory due diligence. …”see in full comparison
Cost of goods sold amounted tosee in full comparison$124,920$52,622 and$35,720$124,920 for the years ended June 30,20242025 and2023,2024,respectively.respectively.The decrease in the cost of goods sold was mainly due to an one time process of the expired products with $103,810 COGS in June 19, 2024..
Operating expenses for the year ended June 30,see in full comparison20242025 and20232024 were$952,450$722,056 and$661,232,$952,450, respectively. Theincreasedecrease was mainly due toincreaseddecreasedpayrollselling expenses, office expenses,travelprofessional expenses,advertising,reserve expenses, andprofessionalstock compensation expenses.
Sales amounted tosee in full comparison$294,670$391,743 and$204,308$294,670 for the years ended June 30,20242025 and2023,2024,respectively.respectively.The increase in sales was mainly due to the launch of new products.
Our net loss for the year ended June 30,see in full comparison20242025 and20232024 was$1,226,362$721,242 and$777,340,$1,226,362, respectively. Theincreasedecrease in net loss was mainly due to the increased cost of goodssoldsold, selling expenses, and operating expenses.
Full comparison: every changed paragraph (9)
On
September 3, 2021, the Company entered into an Assets Acquisition Agreement with Wang’s Property Investment & Management LLC
to purchase 53 units in 19 real estate properties appraised at $7,626, 286.37 for a purchase price of $7,000,000, The purchase price
shall be paid as follows: (i) $1,000,000 on execution of the Agreement, (ii) $2,000,000 within 60 days thereof and (iii) the remainder
by April 10, 2022. The Agreement is subject to customary closing conditions, including, satisfactory due diligence. On September 9, 2021,
the Company entered into a Supplemental Assets Acquisition Agreement with Wang’s Property Investment & Management LLC to amend
and clarify that (i) it was purchasing 19 real estate properties which includes 53 units appraised at $7,626,286.37 for a purchase price
of $7,000,000 and (ii) that it will waive and not conduct due diligence in order for the transaction to proceed. The acquisition has
not been consummated. With the asset acquisition from Wang’s Property Investment & Management LLC, the Company will diversify
its business into property investment and management. By the end of May 2022, the Company ceased the acquisition of Wang’s Property
Investment & Management LLC.
Sales
amounted to $294,670$391,743 and $204,308$294,670 for the years ended
June 30, 20242025 and 2023,2024, respectively.respectively.The increase in sales was mainly due to the launch of new products.
Cost
of goods sold amounted to $124,920$52,622 and $35,720$124,920 for the
years ended June 30, 20242025 and 2023,2024, respectively.respectively.The decrease in the cost of goods sold was mainly due to an one time process of the expired
products with $103,810 COGS in June 19, 2024..
Operating
expenses for the
year ended June 30, 20242025 and 20232024 were $952,450$722,056 and $661,232,$952,450, respectively. The increasedecrease was mainly due
to increaseddecreased payrollselling expenses,
office expenses, travelprofessional expenses, advertising,reserve expenses, and professionalstock compensation expenses.
Our
net loss for the year
ended June 30, 20242025 and 20232024 was $1,226,362$721,242 and $777,340,$1,226,362, respectively. The increasedecrease in
net loss was mainly due to the increased cost
of goods soldsold, selling expenses, and operating expenses.
Level 1— Quoted prices in active markets for identical assets or liabilities.
Level 2— Inputs, other than the quoted prices in active markets, are observable either directly or indirectly.
Level 3— Unobservable inputs based on the Company’s assumptions.
The
Company’s financial
instruments include cashcash, accounts payable, loans, and accountsstocks payable.for investment. Management has estimated that the carrying amounts approximate
their fair value due to the short-term nature.
What changed in the latest 10-Q
Risk Factors
As a “smaller reporting company” as defined by Item 10 of Regulation S-K, the Company is not required to provide information required by this Item.
No wording changes found in this section.
Full comparison: every changed paragraph (0)
Management's Discussion & Analysis (MD&A)
Largest changes
Results of Operations for thesee in full comparisonsixthree and nine months endedDecemberMarch 31,20252026 compared to thesixthree and nine months endedDecemberMarch 31,2024.2025.
“Sales were $26,143 and $56,148 for the three months ended March 31, 2026 and 2025, respectively. The decrease is mainly due to the absence of major wholesale accounts within the U.S. markets For the nine months ended March 31, 2026 and 2025, sales were $258,802 and $287,213, respectively. The temporary gap in bulk wholesale orders within the U.S. market was the key factor leading to the significant year-over-year revenue contraction.”see in full comparison
Costs of goods soldsee in full comparisonamountedwereto $83,444$3,610 and$19,177$6,331 forforthesixthree months endedDecemberMarch 31,20252026 and2024,2025, respectively. The decrease was primarily driven by the decline in sales volume. For the nine months ended March 31, 2026 and 2025, Costs of goods sold were $87,054 and $25,508, respectively. The increase in the cost of goods sold was mainly due tolaunchinglaunch sales of the productsinwholesale with lower gross profit margin.
“Net cash generated in investing activities was $11,000 and $- for the nine months ended March 31, 2026 and March 31, 2025, respectively. The increase was due to the Company disposal of certain obsolete machinery and equipment with a gross book value of $69,881 and related accumulated depreciation of $50,343.”see in full comparison
see in full comparisonOur netNet income (loss) for thesixthree months endedDecemberMarch 31,20252026 and20242025 were$1,027,321($166,216) and ($340,670$158,377), respectively. For the nine months ended March 31, 2026 and 2025, net income (loss) were were $861,105 and ($499,046), respectively. The increase in net income was mainly due to recognizing a non-recurring gain on the extinguishment of debt of$1,395,000.$1,395,000 in the prior quarter.
The accompanying consolidated financial statements have been prepared on a going concerning basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As reflected in the accompanying consolidated financial statements, the Company has incurred recurring net losses. For thesee in full comparisonsixnine months endedDecemberMarch 31,2025,2026, the Company recorded a net income of$1,027,321,$861,105, cash used to fund operating activities of$82,013$80,272 and atDecemberMarch 31,2025,2026, had a shareholders’ deficit of$6,110,116.$4,880,635. For thesixnine months endedDecemberMarch 31,20242025 the Company recorded a net loss of$340,670,$499,046, cash used to fund operating activities of$6,801$60,297 and atDecemberMarch 31,2024,2025, had a shareholders’ deficitdeficitof$5,576,377.$5,523,154. These factors create substantial doubt about the Company’s ability to continue as a going concern. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.
Full comparison: every changed paragraph (20)
On September 3, 2021, the Company entered into
an Assets Acquisition Agreement with Wang’s Property Investment & Management LLC to purchase 53 units in 19 real estate properties
appraised at $7,626, 286.37$7,626,286.37 for a purchase price of $7,000,000, The purchase price shall be paid as follows: (i) $1,000,000 on execution
of the Agreement, (ii) $2,000,000 within 60 days thereof and (iii) the remainder by April 10, 2022. The Agreement is subject to customary
closing conditions, including, satisfactory due diligence. On September 9, 2021, the Company entered into a Supplemental Assets Acquisition
Agreement with Wang’s Property Investment & Management LLC to amend and clarify that (i) it was purchasing 19 real estate properties
which includes 53 units appraised at $7,626,286.37 for a purchase price of $7,000,000 and (ii) that it will waive and not conduct due
diligence in order for the transaction to proceed. The acquisition has not been consummated. With the asset acquisition from Wang’s
Property Investment & Management LLC, the Company will diversify its business into property investment and management. By the end
of May 2022, the Company ceased the acquisition of Wang’s Property Investment & Management LLC.
Results of Operations for the sixthree and nine months ended December March
31, 2025
2026 compared to the sixthree and nine months ended DecemberMarch 31, 2024.2025.
Sales were $26,143 and $56,148 for the three months ended March 31, 2026 and 2025, respectively. The decrease is mainly due to the absence of major wholesale accounts within the U.S. markets For the nine months ended March 31, 2026 and 2025, sales were $258,802 and $287,213, respectively. The temporary gap in bulk wholesale orders within the U.S. market was the key factor leading to the significant year-over-year revenue contraction.
Sales amounted to $232,659 and $231,065 for the
six months ended December 31, 2025 and 2024, respectively.
Costs of goods sold amountedwere to $83,444$3,610 and $19,177$6,331 for
for the sixthree months ended DecemberMarch 31, 20252026 and 2024,2025, respectively. The decrease was primarily driven by the decline in sales volume. For the
nine months ended March 31, 2026 and 2025, Costs of goods sold were $87,054 and $25,508, respectively. The increase in the cost of goods
sold was mainly due to launching
launch sales of the products in wholesale with lower gross profit margin.
Gross profit amountedwere to $149,215$22,533 and $211,888$49,817 for the sixthree months ended March
December31, 2026 and 2025, respectively. For the nine months ended March 31, 20252026 and 2024,2025, Gross profit were $171,748 and $261,705, respectively.
Operating expenses incurred were $96,308 and $135,136 for the sixthree
months ended March 31, 2026 and 2025, respectively. For the nine months ended DecemberMarch 31, 2026 and 2025 operating expenses were $447,682
and 2024 were $351,374 and $403,261,$538,397, respectively. The decrease was in general and administrative expense, mainly due to decreased payroll,
auditing expense,
and professional expense.
Our netNet income (loss) for the sixthree months ended
DecemberMarch 31, 20252026 and 20242025 were $1,027,321($166,216) and ($340,670$158,377), respectively. For the nine months ended March 31, 2026 and 2025, net income (loss)
were were $861,105 and ($499,046), respectively. The increase in net income was mainly due to recognizing a non-recurring
gain on the
extinguishment of debt of $1,395,000.$1,395,000 in the prior quarter.
The accompanying consolidated financial statements
have been prepared on a going concerning basis, which contemplates the realization of assets and the settlement of liabilities and commitments
in the normal course of business. As reflected in the accompanying consolidated financial statements, the Company has incurred recurring
net losses. For the sixnine months ended DecemberMarch 31, 2025,2026, the Company recorded a net income of $1,027,321,$861,105, cash used to fund operating activities
of $82,013$80,272 and at DecemberMarch 31, 2025,2026, had a shareholders’ deficit of $6,110,116.$4,880,635. For the sixnine months ended DecemberMarch 31, 20242025 the Company
recorded a net loss of $340,670,$499,046, cash used to fund operating activities of $6,801$60,297 and at DecemberMarch 31, 2024,2025, had a shareholders’ deficit
deficit of $5,576,377.$5,523,154. These factors create substantial doubt about the Company’s ability to continue as a going concern. The financial
statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.
Our cash needs for the sixnine months ended DecemberMarch
31, 20252026 were primarily met by short term loans and advances from current majority shareholder. As of DecemberMarch 31, 2025,2026, we had a cash balance
of of
$22,904.$29,346. Our new majority shareholders will need to provide parts of our working capitals going forward.
Liquidity and Capital Resources for the sixnine months ended DecemberMarch 31,
20252026 compared to the sixnine months ended DecemberMarch 31, 2024.2025.
Net cash used in operating activities was $82,013$80,272
for the sixnine months ended DecemberMarch 31, 2025,2026, an increase of $75,212$19,975 compared to cash used in operating activities of $6,801$60,297 for the sixnine
months ended DecemberMarch 31, 2024.2025. The increase in net cash used in operating activities was mainly due to the increase of customer advance
advance for the sixnine months ended DecemberMarch 31, 20252026 compared to the same period in 2024.2025.
Net cash generated in investing activities was $11,000 and $- for the nine months ended March 31, 2026 and March 31, 2025, respectively. The increase was due to the Company disposal of certain obsolete machinery and equipment with a gross book value of $69,881 and related accumulated depreciation of $50,343.
None.
Net cash provided from financing activities was
$59,471$52,475 for the sixnine months ended DecemberMarch 31, 2025,2026, compared to $10,877$43,314 net cash usedprovided byfrom financing activities for the sixnine months
ended ended
DecemberMarch 31, 2024.2025. The increase in net cash provided from financing activities for the sixnine months ended DecemberMarch 31, 20252026 was primarily
attributable to a new loan of $50,000 obtained in thisthe last quarter.
As of DecemberMarch 31, 2025,2026, the Company had $22,904$29,346
in cash, negative working capital of $2,404,215$2,478,411 and total deficit attributable to owners of the Company of 4,632,499.$4,797,818. As of
June 30,
2025, we had $44,056 in cash, negative working capital of $3,584,235 and total deficit attributable to owners of the Company
of $5,661,210.
The preparation of these consolidated financial
statements (“CFS”) in accordance with accounting principles generally accepted in the United States of America (“GAAP”)
requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent
assets and liabilities at the dates of the consolidated financial statements and the reported amounts of net sales and expenses during
the reported periods. Actual results may differ from those estimatesestimates, and such differences may be material to the financial statements.
The more significant estimates and assumptions by management includeinclude, among others, the fair value of shares of common stock issued for
services. The current economic environment has increased the degree of uncertainty inherent in these estimates and assumptions.
Inventories are stated at the lower cost (first-in,
first-out) or net realizable value. Adjustments to reduce the cost of inventory to its net realizable value are made, if required, for
estimated excess, obsolescence, or impaired balances. For the sixnine months ended DecemberMarch 31, 20252026 and June 30, 2025, the Company has made
provision of $9,000 both for inventory in regard to slow moving or obsolete items. As of DecemberMarch 31, 20252026 and June 30, 2025, net inventories
amounted to $103,909$97,539 and $164,651, respectively.
Basic earnings (loss) per share are computed
by by
dividing income available to common shareholders by the weighted-average number of common shares available. Diluted earnings (loss)
per per
share is computed similar to basic earnings per share except that the denominator is increased to include the number of additional
common common
shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were
dilutive. dilutive.
The Company’s diluted loss per share is the same as the basic loss per share for the sixnine months ended DecemberMarch 31, 2025 2026
and 2024,
2025, as there are no potential shares outstanding that would have a dilutive effect.
Income tax expense is based on pretax financial
accounting income. Deferred tax assets and liabilities are recognized for the expected tax consequences of temporary differences between
the tax bases of assets and liabilities and their reported amounts. Valuation allowances are recorded to reduce deferred tax assets to
the amount that will more likely than not be realized. The Company recorded the valuation allowance against its deferred tax assets of
$7,618,155$7,784,371 as of DecemberMarch 31, 20252026 and $8,645,476 as of June 30, 2025.
AAGH insider buying and selling (Form 4)
Since 2026-04-11, insiders reported open-market purchases in 0 Form 4 filings and open-market sales in 0 filings. Totals add up every open-market (code P and S) line in those filings, using the prices reported in the filings. Awards, option exercises, tax withholding and gifts are listed below but not counted.
No Form 4 stock transactions in this period.
Well-known investors holding AAGH (13F)
None of the 59 investors we track reported a position in their latest 13F.